(Hypertension. 2001;37:535.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
From the Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Correspondence to Toshihiro Ichiki, MD, Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, 812-8582 Fukuoka, Japan. E-mail ichiki{at}cardiol.med.kyushu-u.ac.jp
Recent studies suggest a crucial role of reactive oxygen species (ROS) for the signaling of angiotensin (Ang) II through Ang II type 1 receptor (AT1-R). However, the role of ROS in the regulation of AT1-R expression has not been explored. In this study, we examined the effect of an antioxidant on the homologous downregulation of AT1-R by Ang II. Ang II (10-6 mol/L) decreased AT1-R mRNA with a peak suppression at 6 hours of stimulation in rat aortic vascular smooth muscle cells. Preincubation of vascular smooth muscle cells with N-acetylcysteine (NAC), a potent antioxidant, almost completely inhibited the Ang IIinduced downregulation of AT1-R mRNA. The effect of NAC was due to stabilization of the AT1-R mRNA that was destabilized by Ang II. The Ang IIinduced AT1-R mRNA downregulation was also blocked by PD98059, an extracellular signalregulated protein kinase (ERK) kinase inhibitor. Ang IIinduced ERK activation was inhibited by NAC as well as by PD98059. Exogenous H2O2 also suppressed AT1-R mRNA. These results suggest that the production of ROS and the activation of ERK are critical for the downregulation of AT1-R mRNA. The generation of ROS through stimulation of AT1-R not only mediates signaling of Ang II but also may play a crucial role in the adaptation process of AT1-R to the sustained stimulation of Ang II.
Key Words: receptor, angiotensin II reactive oxygen species protein kinases
This article has been cited by other articles:
![]() |
M. E. Ullian, A. K. Gelasco, W. R. Fitzgibbon, C. N. Beck, and T. A. Morinelli N-Acetylcysteine Decreases Angiotensin II Receptor Binding in Vascular Smooth Muscle Cells J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2346 - 2353. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Akishita, K. Nagai, H. Xi, W. Yu, N. Sudoh, T. Watanabe, M. Ohara-Imaizumi, S. Nagamatsu, K. Kozaki, M. Horiuchi, et al. Renin-Angiotensin System Modulates Oxidative Stress-Induced Endothelial Cell Apoptosis in Rats Hypertension, June 1, 2005; 45(6): 1188 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A Voors, P. P van Geel, M. Oosterga, H. Buikema, D. J van Veldhuisen, and W. H van Gilst Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism Journal of Renin-Angiotensin-Aldosterone System, September 1, 2004; 5(3): 130 - 134. [Abstract] [PDF] |
||||
![]() |
F. S. Gragasin, Y. Xu, I. A. Arenas, N. Kainth, and S. T. Davidge Estrogen Reduces Angiotensin II-Induced Nitric Oxide Synthase and NAD(P)H Oxidase Expression in Endothelial Cells Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 38 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, D. Kumar, J. R. B. Dyck, W. R. Ford, A. S. Clanachan, G. D. Lopaschuk, and B. I. Jugdutt AT1 and AT2 receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1206 - H1215. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |